Complete Guide to Pre-Treatment Tests for Overseas IVF: Mandatory Checklist & Timeline Planning

Author Identity

Opening: Real Consultation Scenario ===== G Easiest to Overlook Details =====

Easiest to Overlook Details

In overseas IVF pre-treatment testing, the following details are often overlooked but directly impact the validity of test results and subsequent procedures:

• Chromosome testing requires a prior appointment with a genetic counseling clinic. Not all hospitals can directly issue the request form. It usually requires a 1–2 week advance appointment, and the report takes an additional 2–4 weeks.
• AMH testing has a strict time window: Blood must be drawn on days 2–4 of the menstrual cycle. AMH values tested outside of menstruation may be 10%–20% lower, potentially leading to a misjudgment of ovarian reserve.
• Semen analysis requires 2–7 days of abstinence. Abstinence of less than 2 days or more than 7 days can affect concentration and motility results, causing false abnormalities.
• Passport validity must exceed 6 months (some countries require >9 months). Many patients only realize their passport is nearing expiration when they are about to travel, making it impossible to obtain a visa.
• Some destination countries only accept reports from designated hospitals. For example, certain fertility centers in Thailand only accept infectious disease screening and chromosome reports from their partner hospitals. Checking in advance can avoid duplicate testing.

===== A Direct Answer to the Question =====

What Tests are Included in Overseas IVF Pre-Treatment Screening?

According to general standards of domestic and international fertility centers, pre-treatment tests are divided into female and male components. Below are the core mandatory tests:

Mandatory Tests for Women

• Basic Fertility Assessment: AMH, FSH, LH, E2, Antral Follicle Count (AFC) – completed on days 2–4 of the menstrual cycle.
• Chromosome Karyotype Analysis (peripheral blood, valid for life).
• Infectious Disease Screening: Hepatitis B panel, Hepatitis C antibody, HIV, Syphilis serology.
• Thyroid Function: TSH, FT3, FT4 (TSH > 2.5 mIU/L requires adjustment first).
• Complete Blood Count, Coagulation Profile, Liver and Kidney Function.
• Uterine Cavity Assessment: Hysteroscopy or Sonohysterography (to rule out adhesions, polyps, fibroids).

Mandatory Tests for Men

• Semen Analysis: Concentration, motility, morphology. Sperm DNA Fragmentation Index (DFI) is recommended.
• Chromosome Karyotype Analysis (valid for life).
• Infectious Disease Screening: Hepatitis B, Hepatitis C, HIV, Syphilis.
• Genetic Counseling (mandatory if there is a family history of genetic disease or recurrent miscarriage).

===== I Actual Process =====

Actual Process: Completing Pre-Treatment Tests Step by Step

Following the clinical pathway, it is recommended to proceed in the following order to avoid backtracking:

1. Initial Consultation and Individualized Plan Development – The reproductive specialist orders a test checklist based on age, medical history, and past fertility history.
2. Menstrual Cycle Days 2–4 – Blood draw for AMH, FSH, LH, E2, and transvaginal ultrasound for antral follicle count.
3. Basic Tests for Both Partners – Chromosome karyotype analysis, infectious disease screening, complete blood count, coagulation profile, liver and kidney function (can be done on the same day).
4. Male Semen Analysis – Sample collection after 2–7 days of abstinence; DNA fragmentation index is recommended.
5. Uterine Cavity Assessment – Choose hysteroscopy or sonohysterography based on the situation (performed 3–7 days after menstruation ends).
6. Genetic Counseling (if indicated) – Add PGT-related tests if necessary.
7. Document Preparation – Check passport validity (>6 months), apply for a visa, prepare notarized and translated marriage certificate.
8. File Establishment and Ovarian Stimulation Protocol Development – Once all test results are complete, the fertility center establishes the file and the doctor finalizes the protocol.

===== J Timeline Planning =====

Timeline Planning: How Early to Prepare

The turnaround time and validity of different tests vary greatly. Poor planning can lead to unnecessary retesting. The table below outlines the time points for core items:

Test Item	Report Turnaround Time	Validity Period	Notes
AMH	1–2 days	6–12 months	Blood draw during menstruation
Chromosome Karyotype Analysis	2–4 weeks	Valid for life	Requires genetic counseling appointment
Infectious Disease Screening	3–7 days	6–12 months	Some countries require within 3 months
Semen Analysis	1 day	6 months	Abstain for 2–7 days
Uterine Cavity Assessment	1–2 days (appointment needed)	1–2 years	3–7 days after menstruation ends
Passport Application	1–2 weeks	Must have >6 months validity	Check validity in advance
Visa Application	1–4 weeks (varies by country)	Depends on visa type	Allow buffer time

Overall, it is recommended to start pre-treatment tests 3–6 months in advance. Chromosome reports take the longest, and passports and visas also have uncertainties. Starting early can prevent being caught off guard.

===== D Differences by Age Group =====

Differences in Key Tests by Age Group

Age is a core variable affecting fertility and testing strategies. Clinical adjustments are made based on age stratification:

• Under 35 years old: Focus on basic fertility assessment and routine tests, with emphasis on ruling out tubal factors and male factors. AMH and FSH are usually sufficient for assessing reserve.
• 35–40 years old: Intensify ovarian reserve assessment (AMH, FSH, AFC). Genetic counseling is recommended, and PGT should be considered. Keep TSH below 2.5.
• Over 40 years old: Focus on assessing ovarian reserve and the risk of embryonic chromosomal aneuploidy. When AMH < 1.0, the time window is critical. PGT is strongly recommended, along with endometrial receptivity assessment. For men over 40, sperm DNA fragmentation index testing is also advised.

===== L Interpretation of Key Test Results =====

Interpretation of Core Test Indicators

Understanding a few key indicators can help you assess your fertility status:

Indicator	Normal Reference Range	Clinical Significance
AMH	1.0–4.0 ng/mL	Reflects ovarian reserve; <1.0 indicates diminished reserve, <0.5 indicates severely diminished
FSH	3–10 IU/L	Reflects ovarian function; >10 indicates reduced function, >15 indicates significantly reduced reserve
Antral Follicle Count (AFC)	5–15 (both ovaries combined)	Number of basal follicles; <5 indicates insufficient reserve
Semen Concentration	≥15 million/mL	Sperm density; <15 indicates oligospermia
Sperm Motility (PR)	≥32%	Progressive motility; <32% indicates asthenospermia
Normal Sperm Morphology	≥4% (strict criteria)	High abnormal morphology rate may affect fertilization
TSH	0.5–2.5 mIU/L	Thyroid function; >2.5 requires endocrine adjustment before starting the cycle

===== E Differences by Destination Country =====

Differences in Test Requirements by Destination Country

Pre-treatment tests for overseas IVF are not one-size-fits-all. Different countries and even different fertility centers have their own regulations:

• Thailand: Most fertility centers require test reports from designated partner hospitals, especially for infectious disease screening and chromosome reports. Some tests (e.g., HIV, Syphilis) need to be repeated locally in Thailand. It is advisable to obtain a test checklist in advance through an agency or the hospital.
• United States: Accepts reports from domestic top-tier hospitals with English translations. However, some states require genetic counseling and certain infectious disease tests to be completed in the US. Chromosome reports need to provide original report scans plus translations.
• Japan: Requires test reports to be valid within 3 months and needs Japanese translations (notarized or by a designated translation agency). Chromosome tests are recommended to be done in advance in your home country, as the turnaround time for reports in Japan is longer.
• Cambodia: Some tests can be done locally, but basic tests (AMH, semen analysis, chromosomes) are best done in your home country to save time and cost.

Regardless of the destination, confirming the test checklist and validity periods with the fertility center in advance is the safest approach.

===== H Six Most Common Pitfalls =====

Six Most Common Pitfalls

1. Expired Test Reports: AMH, semen analysis, and infectious disease screening are typically valid for 6 months. If they expire, they must be redone. Many people do tests a year in advance, only to find them invalid when starting the cycle.
2. Not Booking Chromosome Tests in Advance: This test requires a genetic counseling clinic appointment. The queue at a top-tier hospital can be 1–3 weeks, plus 2–4 weeks for the report, totaling over a month.
3. Insufficient Passport Validity: Some countries (e.g., Thailand, Cambodia) require passport validity over 6 months, while the US requires over 9 months. If validity is insufficient, renew the passport early.
4. Neglecting Male Tests: Male factors account for about 40% of infertility cases. However, many patients only focus on female tests. If the male semen analysis is done only overseas, discovering a problem can delay the cycle.
5. Not Doing Genetic Counseling in Advance: Those with a family history of genetic disease or recurrent miscarriage need genetic counseling beforehand. Otherwise, a PGT plan cannot be made, potentially requiring an additional consultation overseas.
6. Not Confirming Report Acceptance in the Destination Country: Different countries have different requirements for the source, language, and validity of test reports. Not checking in advance may lead to some tests needing to be redone, increasing time and cost.

===== Special Situations =====

Test Adjustments for Special Situations

AMH < 0.5 ng/mL

Indicates severely diminished ovarian reserve. It is not recommended to spend a lot of time on non-essential tests. After completing core mandatory tests (chromosomes, infectious disease screening, semen analysis), proceed to the cycle as soon as possible. The doctor may use a mild stimulation or natural cycle protocol.

Persistently Abnormal Semen Analysis Results

If repeat testing still shows oligo-, astheno-, or teratozoospermia, it is recommended to add Y chromosome microdeletion, sperm DNA fragmentation index, and reproductive hormones (FSH, LH, testosterone). ICSI or PGT may be necessary.

Recurrent Miscarriage (≥2 times)

In addition to standard tests, add: both partners' chromosome karyotypes, hysteroscopy, coagulation profile (D-dimer, Protein S/C), antiphospholipid antibodies, thyroid autoantibodies, NK cell activity, and other immune-related tests.

===== Q Frequently Asked Questions =====

Frequently Asked Questions

Q: Can overseas IVF pre-treatment tests be done at a domestic top-tier hospital?
A: Yes. Most tests can be completed domestically. However, you must obtain a test checklist from the destination fertility center in advance to confirm acceptance. It is recommended to provide all reports in both Chinese and English.

Q: How long are the test results valid?
A: Chromosome karyotype analysis is valid for life; AMH, semen analysis, and infectious disease screening are usually valid for 6 months; uterine cavity assessment results are valid for 1–2 years. Tests must be redone if they expire.

Q: How many times does the male partner need to travel overseas?
A: The male partner needs to go at least once (for sperm retrieval day + some tests). If work is tight, all male tests can be completed domestically in advance and the reports brought overseas. However, some countries require the male partner to be present for certain signatures or tests.

Q: What is the approximate cost of pre-treatment tests?
A: Completing the full set of tests at a domestic top-tier hospital costs approximately 3000–5000 RMB for women and 2000–3000 RMB for men, depending on the specific tests and hospital level. This does not include invasive procedures like hysteroscopy.

===== R Practitioner's Observation =====

Practitioner's Observation (From a Reproductive Specialist's Perspective)

From a clinical frontline perspective, the two most common problems in overseas IVF pre-treatment testing are "incomplete test panels" and "poor time planning". Many patients go abroad with only basic hormone tests and an ultrasound, only to find they are missing chromosome reports or infectious disease screening. They then have to get these done locally, costing more money and delaying the cycle. Additionally, the timing of the AMH test is critical – an AMH value measured outside of menstruation can be 0.3–0.6 ng/mL lower than the true value, leading the doctor to misjudge ovarian reserve and choose an overly aggressive or conservative stimulation protocol. I usually advise patients to complete AMH and basic hormone testing on days 2–4 of their period for the most reliable data.

Ending: Timeline Reminder

---

This article is based on clinical consensus in assisted reproduction and is intended for patient education reference. Individual circumstances should be discussed with a reproductive medicine center.